Stryker Orthopedics expanded its hip implant safety notification by recalling eight products using LFIT Anatomic CoCr V40 Femoral Heads manufactured before March 4, 2011.
Spinal Tech
Safe Orthopaedics unveiled a deal to acquire Qspine's sales force.
Medicrea received FDA clearance for its patient-specific spinal cages using its UNiD technology.
Xoran Technologies and Fiagon AG Medical Technologies agreed to expand their current collaboration to enter the neuro and spine markets.
The global spine surgery products market is anticipated to experience a 2.63 percent compound annual growth rate through 2022, according to BrooksInBeta.
Advertisement
Here are four key notes for orthopedic and spine device companies from the past week.
The global spinal cord trauma treatment market is expected to grow at a compound annual growth rate of 3.7 percent through 2027, according to a Persistent Market Research report.
Aurora Spine reported its first quarter financial results.
The spinal implant and surgical devices market is predicted to experience a 4.44 percent compound annual growth rate through 2025, according to Crystal Market Research.
Medtronic CEO Omar Ishrak spoke about several key topics during the company's fourth quarter fiscal year 2018 conference call, according to a transcription in Seeking Alpha. Noticeably absent, however, was in-depth discussion about the company's expectations for the Mazor X…